Int J Stroke:原发性脑出血后,微出血的发生率较高

2015-09-18 MedSci MedSci原创

背景:研究人员在以非裔美国人为主的人群中调查了脑出血后,微出血发生次数,并且识别新发微出血的预测因子。 目的和假设:调查脑出血后新发微出血的频数以及预测因子。方法:这项研究是一项前瞻性,纵向,磁共振为基础的队列研究,主要评估微出血危险因素的种族差异,以及评估这类脑出血人群中微出血的预后。研究人员评估了两个时间段的新发微出血:基线到30天间和30天到1年间。结果:共招募200名受试者,84名患者MR

背景:研究人员在以非裔美国人为主的人群中调查了脑出血发生后,微出血发生的次数,并且识别新发微出血的预测因子。

目的和假设:调查脑出血后新发微出血的频率以及预测因子。

方法:这项研究是一项前瞻性,纵向,磁共振为基础的队列研究,主要评估微出血危险因素的种族差异,以及评估这类脑出血人群中微出血的预后。研究人员评估了两个时间段的新发微出血:基线到30天间和30天到1年间。

结果:共招募200名受试者,84名患者MRI显示满足的分析要求。在基线到30天这一时间段的分析中,11(13.1%)名患者存在新发微出血,30天到1年间,有25(29.8%)名受试者存在新发出血。Logistic回归分析显示,微出血的基线值(OR:1.05,95%CI:1.01,1.08)与30天新发微出血相关。Logistic回归模型显示能预测一年内新发微出血:包括微出血基线值(OR:1.05 95%CI:1.00, 1.11),基线年龄(OR:1.05 95%CI:1.00, 1.10),以及白质疾病分数(OR:1.18 95%CI:0.96, 1.45)。总之,84名患者中28名(33.3%)在脑出血后一年形成新发微出血。

结论:研究人员发现1/3的脑内出血的患者,一年内形成新发微出血,表明血管病变多样化快速进展。需要进一步研究新发微出血对患者预后的影响。

原文出处:

Mackey J, Wing JJ, Norato G,et al.High rate of microbleed formation following primary intracerebral hemorrhage. Int J Stroke. 2015 Aug 26.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1846477, encodeId=193e18464e7bb, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Feb 15 12:53:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674837, encodeId=111416e4837b0, content=<a href='/topic/show?id=60fb50501b3' target=_blank style='color:#2F92EE;'>#微出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50501, encryptionId=60fb50501b3, topicName=微出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7927121733, createdName=liuxiaona, createdTime=Tue Dec 15 23:53:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949712, encodeId=8b1e1949e12cf, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 10 11:53:00 CST 2016, time=2016-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826288, encodeId=7ee81826288b1, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Nov 25 07:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1846477, encodeId=193e18464e7bb, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Feb 15 12:53:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674837, encodeId=111416e4837b0, content=<a href='/topic/show?id=60fb50501b3' target=_blank style='color:#2F92EE;'>#微出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50501, encryptionId=60fb50501b3, topicName=微出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7927121733, createdName=liuxiaona, createdTime=Tue Dec 15 23:53:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949712, encodeId=8b1e1949e12cf, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 10 11:53:00 CST 2016, time=2016-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826288, encodeId=7ee81826288b1, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Nov 25 07:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1846477, encodeId=193e18464e7bb, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Feb 15 12:53:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674837, encodeId=111416e4837b0, content=<a href='/topic/show?id=60fb50501b3' target=_blank style='color:#2F92EE;'>#微出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50501, encryptionId=60fb50501b3, topicName=微出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7927121733, createdName=liuxiaona, createdTime=Tue Dec 15 23:53:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949712, encodeId=8b1e1949e12cf, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 10 11:53:00 CST 2016, time=2016-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826288, encodeId=7ee81826288b1, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Nov 25 07:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1846477, encodeId=193e18464e7bb, content=<a href='/topic/show?id=d3a33e0306d' target=_blank style='color:#2F92EE;'>#原发性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37030, encryptionId=d3a33e0306d, topicName=原发性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8e4c53, createdName=jiyangfei, createdTime=Mon Feb 15 12:53:00 CST 2016, time=2016-02-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1674837, encodeId=111416e4837b0, content=<a href='/topic/show?id=60fb50501b3' target=_blank style='color:#2F92EE;'>#微出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50501, encryptionId=60fb50501b3, topicName=微出血)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c7927121733, createdName=liuxiaona, createdTime=Tue Dec 15 23:53:00 CST 2015, time=2015-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1949712, encodeId=8b1e1949e12cf, content=<a href='/topic/show?id=a91e3e11312' target=_blank style='color:#2F92EE;'>#原发性脑出血#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37113, encryptionId=a91e3e11312, topicName=原发性脑出血)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Fri Jun 10 11:53:00 CST 2016, time=2016-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1826288, encodeId=7ee81826288b1, content=<a href='/topic/show?id=e5283e89970' target=_blank style='color:#2F92EE;'>#发生率#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=37899, encryptionId=e5283e89970, topicName=发生率)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=一叶知秋, createdTime=Wed Nov 25 07:53:00 CST 2015, time=2015-11-25, status=1, ipAttribution=)]

相关资讯

Stroke:脑出血患者是否应该服用他汀类药物?

有关ICH患者使用他汀类药物一直存在争议。近期,美国心脏学会和美国卒中学会(AHA/ASA)于《卒中》(Stroke)杂志发布了新版脑出血(ICH)管理指南,或许该指南相关内容能初步解答上述问题。在预防ICH复发方面,指南推荐,尚缺乏足够证据限制ICH患者服用他汀类药物(Ⅱb,C)。以下为该指南制定此项指导意见的相关证据。        SPARC

Neurocrit Care:新型自发性脑出血动物模型可用地研究造影响剂外溢

背景:自发性脑出血(ICH)会引起造影剂外溢(CE),且预示扩大的血肿和不良的预后。但我们对CE增长和ICH之间的动态关系知之甚少。为此我们在活体动物体内进行研究,并使用一种新的急性脑出血动物模型来研究颅内血肿的发生几率。研究方式:我们为了实验需要,利用一种新型的MRI综合模型,并选取了14头有基底节出血的约克郡地区的猪,因此我们可以实时根据动态增强的MRI(DCE)来实时监测造影剂外溢现象(CE

Stroke:脑出血后神经功能障碍的时间进程和预测因素

神经功能障碍(ND)是脑出血后一种的非常严重的并发症,但是我们对其时间进程与预测因素知之甚少。研究方法:我们进行了一项回顾性队列研究,观察对象为脑出血试验中的安慰剂患者。我们分别在出现症状3小时内、24小时、72小时对患者行CT扫描,并对1小时、1至3天、15天的基线资料进行临床评价。我们对ND进行了如下定义:超急性(1小时内)、急性(1-24小时内)、亚急性(1-3天)、延迟性(3-15天)。研

BMJ:抗抑郁药联合止痛药导致出血风险升高

近期发布于著名期刊BMJ的一篇研究报道显示,同时使用了抗抑郁药和常规止痛药后会导致给药后出血的风险迅速上升。研究人员表示他们的实验结果可能受到了一些未知因素的影响,需要谨慎解释。然而,本研究的结果仍提示了患者同时服用以上两类药物时须特别注意。抑郁症是所有的慢性疾病症状中最消耗健康的一种疾病,目前老年人抑郁症现象已经成为了一项严重的公共卫生难题。然而始终有一种关于抗抑郁症药物使用的焦虑存在,即担心其

专家对于抗抑郁药联合止痛药会升高出血风险的讨论

为了检测了两种药物同时服用后可能造成的协同反应对颅骨内出血的影响,研究学者已在The BMJ杂志发布了一篇研究论著,报道了与单独服用抗抑郁药物的患者相比,同时服用抗抑郁药物与止痛药的患者的颅内出血风险会显著增高。伦敦King’s College大学药学院药物医学专业Tony Fox教授:本文比较了单独服用抗抑郁药组与联合服用抗抑郁药与非甾体类抗炎药(NSAIDs)组的患者,得到结果总体风险比为1.

Stroke:涂层血小板水平影响脑出血后的死亡率

背景:涂层血小板是高度促进凝血的血小板,可以通过胶原和凝血酶双重激动剂刺激观察得到。与对照组相比,自发性脑出血患者的涂层血小板水平下降,并与出血量呈负相关。研究人员试图调查涂层血小板水平是否与自发性脑出血后30天的死亡率增加相关联。方法:在95例自发性脑出血患者中测定涂层血小板的水平。研究的主要终点是根据招募时涂层血小板水平,检测30天的死亡率。受试者通过观察涂层血小板水平分布被分为3组。涂层血小